The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Identification of intracellular carriers for the endocannabinoid anandamide
Abstract
The endocannabinoid anandamide (arachidonoyl ethanolamide, AEA) is an uncharged neuromodulatory lipid that, similar to many neurotransmitters, is inactivated through its cellular uptake and subsequent catabolism. AEA is hydrolyzed by fatty acid amide hydrolase (FAAH), an enzyme localized on the endoplasmic reticulum. In contrast to most neuromodulators, the hydrophilic cytosol poses a diffusional barrier for the efficient delivery of AEA to its site of catabolism. Therefore, AEA likely traverses the cytosol with the assistance of an intracellular carrier that increases its solubility and rate of diffusion. To study this process, AEA uptake and hydrolysis were examined in COS-7 cells expressing FAAH restricted to the endoplasmic reticulum, mitochondria, or the Golgi apparatus. AEA hydrolysis was detectable at the earliest measurable time point (3 seconds), suggesting that COS-7 cells, normally devoid of an endocannabinoid system, possess an efficient cytosolic trafficking mechanism for AEA. Three fatty acid binding proteins (FABPs) known to be expressed in brain were examined as possible intracellular AEA carriers. AEA uptake and hydrolysis were significantly potentiated in N18TG2 neuroblastoma cells after overexpression of FABP5 or FABP7, but not FABP3. Similar results were observed in COS-7 cells stably expressing FAAH. Consistent with the roles of FABP as AEA carriers, administration of the competitive FABP ligand oleic acid or the selective non-lipid FABP inhibitor BMS309403 attenuated AEA uptake and hydrolysis by ≈50% in N18TG2 and COS-7 cells. Taken together, FABPs represent the first proteins known to transport AEA from the plasma membrane to FAAH for inactivation and may therefore be novel pharmacological targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FABP7 is a brain-specific lipid chaperone for cytosolic trafficking of PUFAs and eCBs.
“FABP7 is a brain-specific lipid chaperone for cytosolic trafficking of PUFAs and eCBs50–52.”
From Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel (2025) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Structure and function of fatty acid amide hydrolase
McKinney, M. K., & Cravatt, B. F. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133450 · Cited by 680
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
Flagged first, then by citations
Research works printed but not linked: 62
- 10.1126/science.1470919 · DOI · Paper page
- 10.1038/346561a0 · DOI · Paper page
- 10.1016/S0014-2999(02)01996-9 · DOI
- 10.1038/22761 · DOI · Paper page
- 10.1124/pr.54.2.161 · DOI · Paper page
- 10.1021/jm058183t · DOI
- 10.1194/jlr.M400498-JLR200 · DOI
- 10.1073/pnas.0730816100 · DOI
- 10.1074/jbc.M509721200 · DOI
- 10.1046/j.1432-1033.2003.03724.x · DOI
- 10.1021/bi049395f · DOI
- 10.1016/j.chemphyslip.2004.12.010 · DOI
- 10.1038/372686a0 · DOI
- 10.1126/science.277.5329.1094 · DOI · Paper page
- 10.1046/j.1471-4159.1997.69020631.x · DOI
- 10.1074/jbc.M407250200 · DOI
- 10.1074/jbc.M411642200 · DOI
- 10.1016/0006-2952(93)90486-G · DOI
- 10.1038/384083a0 · DOI · Paper page
- 10.1038/sj.bjp.0705468 · DOI
- 10.1016/j.lfs.2005.05.007 · DOI
- 10.1016/S0009-3084(00)00191-2 · DOI
- 10.1038/nrd2589 · DOI
- 10.1016/S0891-0618(96)00192-5 · DOI
- 10.1023/A:1020524621933 · DOI
- 10.1007/s00418-001-0354-2 · DOI
- 10.1074/jbc.M314263200 · DOI
- 10.1373/clinchem.2003.030361 · DOI
- 10.1038/nature05844 · DOI
- 10.1016/j.cell.2007.02.050 · DOI · Paper page
- 10.1074/jbc.M606646200 · DOI
- 10.1021/bi981733n · DOI
- 10.1083/jcb.151.2.277 · DOI
- 10.1016/S0092-8674(00)80407-9 · DOI
- 10.1007/s00018-004-4446-8 · DOI
- 10.1124/mol.59.6.1369 · DOI
- 10.1074/jbc.M003161200 · DOI
- 10.1194/jlr.M700486-JLR200 · DOI
- AC Howlett, Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol Pharmacol 27, 429–436 (1985). · DOI
- 10.1016/0014-5793(95)01311-3 · DOI
- 10.1021/bi047292r · DOI
- 10.1111/j.1460-9568.2006.04855.x · DOI · Paper page
- 10.1242/dev.120.9.2637 · DOI · Paper page
- 10.1023/A:1020502624234 · DOI
- 10.1016/j.bmcl.2006.12.044 · DOI
- 10.1016/S0083-6729(01)62002-8 · DOI
- 10.1007/s11745-001-0809-2 · DOI
- 10.1016/0896-6273(94)90341-7 · DOI · Paper page
- 10.1016/S0014-5793(00)01223-0 · DOI
- 10.1016/j.bbalip.2005.08.010 · DOI
- BA Luxon, RA Weisiger, Sex differences in intracellular fatty acid transport: role of cytoplasmic binding proteins. Am J Physiol 265, G831–G841 (1993).
- 10.1007/s12031-007-0047-y · DOI
- Y Sun, SPH Alexander, DA Kendall, AJ Bennett Involvement of fatty acid binding proteins in the transport of endocannabinoids to peroxisome proliferator activated receptors (International Cannabinoid Research Society, Burlington, VT), pp. 17. 1 (2008).
- F Rakhshan, TA Day, RD Blakely, EL Barker, Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J Pharmacol Exp Ther 292, 960–967 (2000). · DOI
- 10.1021/ja062999h · DOI
- 10.1007/s10571-006-9072-6 · DOI
- 10.1016/S0006-2952(03)00109-6 · DOI
- 10.1073/pnas.0400997101 · DOI · Paper page
- 10.1038/nature01921 · DOI
- 10.1124/mol.104.006353 · DOI · Paper page
- 10.1016/S0021-9258(17)31599-5 · DOI
- 10.1038/nrd2553 · DOI
Cited by
Sorted by citations
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555
“Fatty acid-binding proteins (FABPs) have been reported to play an important role as intracellular carriers in the transport of AEA from the plasma membrane to FAAH for their subsequent inactivation [12].”
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., Guijarro, A., Lodola, A., Armirotti, A., Garau, G., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.2986 · Cited by 175
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
Kaczocha, M., Rebecchi, M. J., Ralph, B. P., Teng, Y.-H. G., Berger, W. T., Galbavy, W., Elmes, M. W., Glaser, S. T., Wang, L., Rizzo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094200 · Cited by 142
“(FAAH), the principal NAE hydrolyzing enzyme in mice [8,9,26].”
BackgroundMethodInfluentialSelf-citationRole of the endocannabinoid system in the regulation of intestinal homeostasis
Cuddihey, H., MacNaughton, W. K., & Sharkey, K. A. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.05.015 · Cited by 79
Kaczocha, M., Glaser, S. T., Maher, T., Clavin, B., Hamilton, J., Rourke, J. O., Rebecchi, M., Puopolo, M., Owada, Y., & Thanos, P. K. (2015) · Molecular Pain · doi:10.1186/s12990-015-0056-8 · Cited by 68
Self-citationLowin, T., Pongratz, G., & Straub, R. H. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0114-7 · Cited by 52
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms
Sirrs, S., van Karnebeek, C. D., Peng, X., Shyr, C., Tarailo-Graovac, M., Mandal, R., Testa, D., Dubin, D., Carbonetti, G., Glynn, S. E., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0248-3 · Cited by 28
Self-citationGreda, A. K., Gomes, J. P., Schmidt-Krueger, V., Zurawska-Plaksej, E., Fritsche-Guenther, R., Rudolph, I.-M., Telugu, N. S., Cömert, C., Kirwan, J., Kunz, S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01389-5 · Cited by 21
Metadata
- Authors
- Kaczocha, M., Glaser, S. T., & Deutsch, D. G.
- Affiliations
- Departments of aBiochemistry and Cell Biology and
- Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-14
- Volume
- 106
- Issue
- 15
- Pages
- 6375-6380
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 326
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review